Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
- PMID: 26877917
- PMCID: PMC4713917
- DOI: 10.1016/j.krcp.2013.04.003
Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
Abstract
Colchicine is a relatively safe medication that is widely used for both prevention and treatment of gout attack. However, serious adverse events, including myoneuropathy and multiorgan failure, have been reported. We report a case of colchicine-induced myoneuropathy in a female kidney transplant recipient who had been taking cyclosporine. She developed gastrointestinal discomfort and paresthesia 5 days after the initiation of colchicine. She showed signs of myoneuropathy, and hepatic and renal injury. Colchicine toxicity was suspected, and colchicine was discontinued. Her symptoms and laboratory findings improved gradually. Literature was reviewed for previous reports of colchicine-induced myoneuropathy in solid organ transplant recipients.
Keywords: Colchicine; Cyclosporine; Gout; Myoneuropathy; Renal transplant.
References
-
- Lin H.Y., Rocher L.L., McQuillan M.A., Schmaltz S., Palella T.D., Fox I.H. Cyclosporine-induced hyperuricemia and gout. N Engl J Med. 1989;321:287–292. - PubMed
-
- Kuncl R.W., Duncan G., Watson D., Alderson K., Rogawski M.A., Peper M. Colchicine myopathy and neuropathy. N Engl J Med. 1987;316:1562–1568. - PubMed
-
- Minetti E.E., Minetti L. Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine. J Nephrol. 2003;16:421–425. - PubMed
-
- Ducloux D., Schuller V., Bresson-Vautrin C., Chalopin J.M. Colchicine myopathy in renal transplant recipients on cyclosporin. Nephrol Dial Transplant. 1997;12:2389–2392. - PubMed
-
- Jagose J.T., Bailey R.R. Muscle weakness due to colchicine in a renal transplant recipient. N Z Med J. 1997;110:343. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
